Purpose of the Test
- Detecting ABO or Rh blood group incompatibilities.
- Diagnosing the cause of early-onset neonatal jaundice.
- Assessing the risk of Hemolytic Disease of the Newborn (HDN).
A vital postnatal screening that detects maternal antibodies attached to the newborn's red blood cells, preventing complications like jaundice or hemolytic disease through early diagnosis and immediate medical care.
Scientific name: Postnatal Direct Antiglobulin Test (DAT/Coombs)
This test analyzes umbilical cord or infant blood to identify maternal antibodies attacking red blood cells. It is essential for managing blood group incompatibilities (ABO or Rh) between mother and child.